These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15381393)

  • 41. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of intravascular coagulation.
    Kisker CT; Rush R
    J Clin Invest; 1971 Nov; 50(11):2235-41. PubMed ID: 5096509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Soluble fibrin monomer complex (SFMC), soluble fibrin monomer (SFM)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():600-3. PubMed ID: 15658400
    [No Abstract]   [Full Text] [Related]  

  • 44. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.
    Kushimoto S; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Seki Y; Hatada T; Imai H; Nobori T;
    Clin Appl Thromb Hemost; 2012 Nov; 18(6):628-32. PubMed ID: 22751910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of thrombin-induced fibrinogen derivatives in thrombotic states.
    Heene DL; Matthias FR
    Bibl Haematol; 1977; 44():161-8. PubMed ID: 617780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
    Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence that fibrin alpha-chain RGDX sequences are not required for platelet adhesion in flowing whole blood.
    Hantgan RR; Endenburg SC; Sixma JJ; de Groot PG
    Blood; 1995 Aug; 86(3):1001-9. PubMed ID: 7620153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.
    Cox S; Cole M; Tawil B
    Tissue Eng; 2004; 10(5-6):942-54. PubMed ID: 15265312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How does association process affect fibrinogen hydrolysis by thrombin?
    Zavyalova E; Kopylov A
    Biochimie; 2014 Dec; 107 Pt B():216-22. PubMed ID: 25239831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast migration in fibrin gel matrices.
    Brown LF; Lanir N; McDonagh J; Tognazzi K; Dvorak AM; Dvorak HF
    Am J Pathol; 1993 Jan; 142(1):273-83. PubMed ID: 8424460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The significance of soluble fibrin (soluble fibrin-complex) for consumption coagulopathy].
    Müller-Berghaus G; Mahn I; Obst I; Maul FD
    Med Welt; 1975 Nov; 26(48):2163-6. PubMed ID: 1207451
    [No Abstract]   [Full Text] [Related]  

  • 54. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm.
    Hosaka A; Miyata T; Aramoto H; Shigematsu H; Nakazawa T; Okamoto H; Shigematsu K; Nagawa H
    J Vasc Surg; 2005 Aug; 42(2):200-5. PubMed ID: 16102614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo behaviour of homologous urea-soluble 131I-fibrin and 125I-fibrinogen in rabbits: the effect of fibrinolysis inhibition.
    Müller-Berghaus G; Mahn I; Köveker G; Maul FD
    Br J Haematol; 1976 May; 33(1):61-79. PubMed ID: 1268091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparin-binding domain of fibrin mediates its binding to endothelial cells.
    Odrljin TM; Francis CW; Sporn LA; Bunce LA; Marder VJ; Simpson-Haidaris PJ
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1544-51. PubMed ID: 8977460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
    Weinstein MJ; Deykin D
    Br J Haematol; 1978 Dec; 40(4):617-30. PubMed ID: 728374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on circulating soluble fibrin: separation of 125I-Des-AB fibrin and 131I-fibrinogen by gel filtration.
    Kröhnke I; Mahn I; Krell W; Müller-Berghaus G
    Br J Haematol; 1980 May; 45(1):131-41. PubMed ID: 6769465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.